说明公司下属公司经营范围涉及设计、制作、代理发布国内各类广告，以及数据处理和存储支持服务、 互联网数据服务的具体情况，是否实际开展相关业务并取得必要的资质许可，并就公司及下属公司经营 范围、实际业务、资质许可是否涉及限制或禁止外商投资领域业务出具明确结论性意见。 说明公司及下属公司是否涉及开发、运营网站、小程序、APP、公众号等产品，是否涉及向第三方提供 信息内容，提供信息内容的类型以及信息内容安全保护措施;同时说明收集及储存的用户信息规模、数 据收集使用情况，上市前后个人信息保护和数据安全的安排或措施。 说明备案材料对控股股东认定结果不一致的原因及认定标准，并就控股股东的认定情况出具明确结论性 意见。 对照《监管规则适用指引——境外发行上市类第2号：备案材料内容和格式指引》要求，(1)完善说明发 行上市方案，备案材料及招股说明书关于发行上市方案内容不一致的原因；(2)说明公司及下属公司涉 及重大诉讼的具体情况及审理进展。 说明本次拟参与"全流通"股东所持股份是否存在被质押、冻结或其他权利瑕疵的情形。 1月30日，中国证监会公布境外发行上市备案补充材料要求公示(2026年1月26日—2026年1月30日)。证 ...

说明公司下属公司经营范围涉及设计、制作、代理发布国内各类广告，以及数据处理和存储支持服务、 互联网数据服务的具体情况，是否实际开展相关业务并取得必要的资质许可，并就公司及下属公司经营 范围、实际业务、资质许可是否涉及限制或禁止外商投资领域业务出具明确结论性意见。 说明公司及下属公司是否涉及开发、运营网站、小程序、APP、公众号等产品，是否涉及向第三方提供 信息内容，提供信息内容的类型以及信息内容安全保护措施;同时说明收集及储存的用户信息规模、数 据收集使用情况，上市前后个人信息保护和数据安全的安排或措施。 智通财经APP获悉，1月30日，中国证监会公布境外发行上市备案补充材料要求公示(2026年1月26日— 2026年1月30日)。证监会要求擎天全税通详述公司业务是否涉及AI大模型，包括应用场景、具体功能 等。据港交所2025年10月17日披露，擎天全税通向港交所主板提交上市申请书，中金公司、工银国际为 其联席保荐人。 同时，证监会要求擎天全税通补充说明以下事项，请律师核查并出具明确的法律意见： 说明备案材料对控股股东认定结果不一致的原因及认定标准，并就控股股东的认定情况出具明确结论性 意见。 对照《监管规则 ...

Core Viewpoint - The Hong Kong Stock Exchange reported that during the week from October 13 to October 19, 9 companies submitted listing applications, 5 companies passed the hearing, 4 companies launched their IPOs, and 2 new stocks were listed [1]. Group 1: Companies Submitted Listing Applications - Hantian Technology (Xiamen) Co., Ltd. is a leader in the global silicon carbide (SiC) epitaxy industry, focusing on the R&D, mass production, and sales of SiC epitaxy chips, with a projected market share of over 30% in 2024 [2]. - Impression Co., Ltd. is a state-owned cultural tourism service enterprise, ranking eighth in China's cultural tourism performance market in 2024, with revenues of approximately 63.04 million yuan in 2022 [3]. - Guangzhou Yujian Noodle Restaurant Co., Ltd. is the fourth largest operator of Chinese noodle restaurants in China, with a market share of 0.5% in 2024 [4]. - Baishan Cloud Holdings Ltd. is the second largest independent edge cloud service provider in China, with a market share of approximately 2.0% in 2024 [5][6]. - Shouchuang Securities Co., Ltd. is a financial service provider with a strong asset management capability, ranking fifth in revenue growth among 42 A-share listed securities companies from 2022 to 2024 [7]. - Chongqing Qianli Technology Co., Ltd. focuses on AI and mobility solutions, with stable growth in automotive products [8]. - Nanjing Qingtian All Tax Information Technology Co., Ltd. is a leading digital service provider for cross-border enterprises, ranking first in the smart tax solution market in China with a market share of 1.7% in 2024 [9]. - Lakala Payment Co., Ltd. is a leading digital payment provider in Asia, with a market share of 9.4% in 2024 [10]. - Sichuan Xin Hehua Traditional Chinese Medicine Co., Ltd. is one of the largest suppliers of traditional Chinese medicine products in China, ranking second in the market with a 0.4% market share in 2024 [12]. Group 2: Companies Passed Hearing - Seres Group Co., Ltd. focuses on the research, manufacturing, and sales of new energy vehicles, achieving revenues of approximately 340.56 billion yuan in 2022 [13]. - Minglue Technology is a leading data intelligence application software company in China, with revenues of approximately 12.69 billion yuan in 2022 [14]. - Pony AI Inc. specializes in autonomous driving services, with a total operational area exceeding 2000 square kilometers [15]. - Ningbo Joyson Electronic Corp. is a global leader in smart automotive technology solutions, ranking second in China and fourth globally in smart cockpit domain control systems [16][17]. - WeRide Inc. is a pioneer in L4 autonomous driving, with operations in over 30 cities across 11 countries [18]. Group 3: Companies Launched IPOs - Yunji Technology launched its IPO with a subscription that was oversubscribed by 5677 times, raising approximately 189.1 billion HKD [19]. - Haixi New Drug's IPO was delayed for regulatory approval, with a price range of 69.88-86.40 HKD per share [20]. - Jushuitan's IPO was set at 30.60 HKD per share, with a total of 681.66 million shares offered [21]. - Guanghetong's IPO was priced between 19.88-21.5 HKD per share, with a total of approximately 135 million shares offered [21]. Group 4: Newly Listed Stocks - Xuan Bamboo Biotechnology was listed on October 15, 2025, with a closing price of 26.30 HKD per share, reflecting a gain of 126.72% [22]. - Yunji was listed on October 16, 2025, with a closing price of 120.5 HKD per share, reflecting a gain of 26.05% [24].